U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT07530757) titled 'SuperCAP Program to Improve Cognition and Daily Functioning in Post-COVID-19 Condition' on March 31.
Brief Summary: The goal of this study is to determine whether the SuperCAP intervention program is superior to control in reducing disability from baseline to the post-intervention assessment in people with Post-COVID-19 Condition.
The main question it aims to answer is whether participants assigned to SuperCAP experience a greater reduction in disability, defined as an improvement of at least 5 points on the WHODAS 2.0 from baseline to the post-intervention visit, compared with participants in the control group.
Participants assi...